3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Non-Small Cell Lung Cancer ALK-positive
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
Cisplatin
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
pembrolizumab
7
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
Carboplatin
6
durvalumab
5
Radiation
5
cemiplimab
4
Radiotherapy
4
Paclitaxel
4
Fluorouracil
4
Cetuximab
4
Biopsy
4
poly ICLC
3
Radiotherapy, Intensity-Modulated
3
Oxaliplatin
3
Nivolumab
3
Ipilimumab
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
cabozantinib
2
Taxes
2
Pemetrexed
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Capecitabine
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
lorlatinib
×
30 days
×
Clear all
No trials found.